TIZONA Trademark

Trademark Overview

On Wednesday, June 10, 2015, a trademark application was filed for TIZONA with the United States Patent and Trademark Office. The USPTO has given the TIZONA trademark a serial number of 86984351. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, August 6, 2025. This trademark is owned by Vesuvius Pharmaceuticals, Inc.. The TIZONA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development of pharmaceuticals and compounds for the treatment of cancer and autoimmune diseases; research and development of pharmaceuticals and compounds for modulation of the immune system and the tumor microenvironment
tizona

General Information

Serial Number86984351
Word MarkTIZONA
Filing DateWednesday, June 10, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, August 6, 2025
Registration Number5715897
Registration DateTuesday, April 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2015

Trademark Statements

Goods and Servicesresearch and development of pharmaceuticals and compounds for the treatment of cancer and autoimmune diseases; research and development of pharmaceuticals and compounds for modulation of the immune system and the tumor microenvironment

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 15, 2015
Primary Code042
First Use Anywhere DateMonday, May 16, 2016
First Use In Commerce DateMonday, May 16, 2016

Trademark Owner History

Party NameTIZONA THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameTIZONA THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02138
Party NameVesuvius Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameVesuvius Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Saturday, June 13, 2015NEW APPLICATION ENTERED
Monday, June 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 19, 2015ASSIGNED TO EXAMINER
Saturday, September 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 14, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 3, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 3, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 13, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 29, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, June 29, 2016SOU EXTENSION 1 FILED
Wednesday, June 29, 2016SOU EXTENSION 1 GRANTED
Friday, July 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 16, 2016SOU TEAS EXTENSION RECEIVED
Friday, December 16, 2016SOU EXTENSION 2 FILED
Friday, December 16, 2016SOU EXTENSION 2 GRANTED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 16, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 16, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 17, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 17, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 28, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, June 28, 2017SOU EXTENSION 3 FILED
Wednesday, June 28, 2017SOU EXTENSION 3 GRANTED
Friday, June 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 29, 2017SOU EXTENSION 4 FILED
Tuesday, January 2, 2018TEAS PETITION TO REVIVE RECEIVED
Tuesday, January 2, 2018PETITION TO REVIVE-GRANTED
Tuesday, January 2, 2018SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, January 3, 2018NOTICE OF REVIVAL - E-MAILED
Friday, January 26, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 30, 2018SOU EXTENSION 4 GRANTED
Wednesday, January 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 29, 2018SOU TEAS EXTENSION RECEIVED
Friday, June 29, 2018SOU EXTENSION 5 FILED
Monday, July 2, 2018SOU EXTENSION 5 GRANTED
Tuesday, July 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 26, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, December 26, 2018TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 26, 2018DIVISIONAL REQUEST RECEIVED
Wednesday, December 26, 2018USE AMENDMENT FILED
Tuesday, January 8, 2019ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Monday, January 14, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 30, 2019DIVISIONAL PROCESSING COMPLETE
Wednesday, January 30, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 27, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 28, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 2, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 2, 2025TEAS SECTION 8 & 15 RECEIVED
Wednesday, August 6, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 6, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, August 6, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

tizona research pharmaceuticals compounds development system tumor microenvironment immune autoimmune treatment